Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice
Guillaume Darrasse-Jèze, … , Katrina Podsypanina, David Klatzmann
Guillaume Darrasse-Jèze, … , Katrina Podsypanina, David Klatzmann
Published August 3, 2009
Citation Information: J Clin Invest. 2009;119(9):2648-2662. https://doi.org/10.1172/JCI36628.
View: Text | PDF
Research Article Immunology

Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice

  • Text
  • PDF
Abstract

Early responses of Tregs and effector T cells (Teffs) to their first encounter with tumor cells have been poorly characterized. Here we have shown, in both implanted and in situ–induced mouse tumor models, that the appearance of tumor cells is immediately sensed by CD44hi memory Tregs that are specific for self antigens. The rapid response of these Tregs preceded and prevented activation of naive antitumor Teffs. The relative speed of the Treg versus the Teff response within the first 2–4 days determined the outcome of the antitumor immune response: tolerance or rejection. If antitumor memory Teffs were present at the time of tumor emergence, both Tregs and Teffs were recruited and activated with memory kinetics; however, the Tregs were unable to control the Teffs, which eradicated the tumor cells. This balance between effector and regulatory responses did not depend on the number of Tregs and Teffs, but rather on their memory status. Thus, in the natural setting, dominant tolerogenic immunosurveillance by self-specific memory Tregs protects tumors, just as it protects normal tissues. More generally, our results reveal that the timing of Treg and Teff engagement, determined by their memory status, is an important mode of regulation of immune responses.

Authors

Guillaume Darrasse-Jèze, Anne-Sophie Bergot, Aurélie Durgeau, Fabienne Billiard, Benoît L. Salomon, José L. Cohen, Bertrand Bellier, Katrina Podsypanina, David Klatzmann

×

Figure 5

Early accumulation of proliferating Tregs in dLNs is antigen driven and self-antigen specific.

Options: View larger image (or click on image) Download as PowerPoint
Early accumulation of proliferating Tregs in dLNs is antigen driven and ...
(A) We adoptively transferred 1-day AB1/AB1-HA or 4T1/4T1-HA tumor-bearing Thy1.2 mice with CFSE-labeled cells from TCR-HA Thy1.1 mice. The presence of HA-specific TCR-HA+ cells among CD4+Foxp3+Thy1.1+ Tregs was evaluated at day 3 after adoptive transfer in dLNs and ndLNs, and CFSE profiles were also determined in the 6.5+ subpopulations. Numbers in boxed regions denote 6.5+ cells, and corresponding percentages are also shown graphically. Numbers within histograms denote percent CFSE– and CFSEint cells, as defined in Figure 1A. Each panel is representative of 3 mice. *P < 0.01, **P < 0.001 versus respective control. (B) CD4+CD25– T cells, naive CD4+CD25hiCD62LhiCD44lo Tregs, and CD4+CD25hiCD62LloCD44hi amTregs were sorted from the pancreatic (Panc) or peripheral (Peri) pooled LNs of InsHA mice by flow cytometry. cDNAs were used in a Vβ8.2-Jβ2.1 first PCR; products were then amplified by QPCR using TCR-HA clonotype primers. Results are shown relative to wild type. (C) Tumor dLNs (n = 3) and TILs (pooled) from 5-day 4T1-HA or 4T1 tumor-bearing InsHA mice and peripheral or pancreatic LNs (n = 3) from normal tumor-free InsHA mice were harvested. cDNAs were directly amplified by QPCR using TCR-HA clonotype primers. Results (mean ± SEM) are shown relative to LNs from TCR-HA mice, used as a positive control.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts